[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Global Viral Vector Manufacturing Market Size, Status and Forecast 2020-2026

June 2020 | 98 pages | ID: C388ADE2979BEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Viral Vector Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Viral Vector Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Viral Vector Manufacturing market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Viral Vector Manufacturing industry.
The key players covered in this study
  • BioReliance
  • Cobra Biologics
  • Oxford BioMedica
  • UniQure
  • FinVector
  • MolMed
  • MassBiologics
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • Biovian
  • Brammer Bio
Market segment by Type, the product can be split into
  • Retroviral Vectors
  • Adenoviral Vectors
  • Adeno-associated Viral Vectors
  • Other Viral Vectors
Market segment by Application, split into
  • Pharmaceutical and Biopharmaceutical Companies
  • Research Institutes
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Viral Vector Manufacturing status, future forecast, growth opportunity, key market and key players.
  • To present the Viral Vector Manufacturing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Viral Vector Manufacturing are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vector Manufacturing Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global Viral Vector Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Retroviral Vectors
  1.4.3 Adenoviral Vectors
  1.4.4 Adeno-associated Viral Vectors
  1.4.5 Other Viral Vectors
1.5 Market by Application
  1.5.1 Global Viral Vector Manufacturing Market Share by Application: 2020 VS 2026
  1.5.2 Pharmaceutical and Biopharmaceutical Companies
  1.5.3 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vector Manufacturing Industry Impact
  1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.6.2 Covid-19 Impact: Commodity Prices Indices
  1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Covid-19 Implications on Global Viral Vector Manufacturing Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global Viral Vector Manufacturing Growth Trends by Regions
  2.2.1 Viral Vector Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Viral Vector Manufacturing Historic Market Share by Regions (2015-2020)
  2.2.3 Viral Vector Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Viral Vector Manufacturing Market Growth Strategy
  2.3.6 Primary Interviews with Key Viral Vector Manufacturing Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Viral Vector Manufacturing Players by Market Size
  3.1.1 Global Top Viral Vector Manufacturing Players by Revenue (2015-2020)
  3.1.2 Global Viral Vector Manufacturing Revenue Market Share by Players (2015-2020)
  3.1.3 Global Viral Vector Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vector Manufacturing Market Concentration Ratio
  3.2.1 Global Viral Vector Manufacturing Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing Revenue in 2019
3.3 Viral Vector Manufacturing Key Players Head office and Area Served
3.4 Key Players Viral Vector Manufacturing Product Solution and Service
3.5 Date of Enter into Viral Vector Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global Viral Vector Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Viral Vector Manufacturing Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global Viral Vector Manufacturing Market Size by Application (2015-2020)
5.2 Global Viral Vector Manufacturing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA IMPACT OF COVID-19

6.1 North America Viral Vector Manufacturing Market Size (2015-2020)
6.2 Viral Vector Manufacturing Key Players in North America (2019-2020)
6.3 North America Viral Vector Manufacturing Market Size by Type (2015-2020)
6.4 North America Viral Vector Manufacturing Market Size by Application (2015-2020)

7 EUROPE IMPACT OF COVID-19

7.1 Europe Viral Vector Manufacturing Market Size (2015-2020)
7.2 Viral Vector Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Viral Vector Manufacturing Market Size by Type (2015-2020)
7.4 Europe Viral Vector Manufacturing Market Size by Application (2015-2020)

8 CHINA IMPACT OF COVID-19

8.1 China Viral Vector Manufacturing Market Size (2015-2020)
8.2 Viral Vector Manufacturing Key Players in China (2019-2020)
8.3 China Viral Vector Manufacturing Market Size by Type (2015-2020)
8.4 China Viral Vector Manufacturing Market Size by Application (2015-2020)

9 JAPAN IMPACT OF COVID-19

9.1 Japan Viral Vector Manufacturing Market Size (2015-2020)
9.2 Viral Vector Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Viral Vector Manufacturing Market Size by Type (2015-2020)
9.4 Japan Viral Vector Manufacturing Market Size by Application (2015-2020)

10 SOUTHEAST ASIA IMPACT OF COVID-19

10.1 Southeast Asia Viral Vector Manufacturing Market Size (2015-2020)
10.2 Viral Vector Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vector Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vector Manufacturing Market Size by Application (2015-2020)

11 INDIA IMPACT OF COVID-19

11.1 India Viral Vector Manufacturing Market Size (2015-2020)
11.2 Viral Vector Manufacturing Key Players in India (2019-2020)
11.3 India Viral Vector Manufacturing Market Size by Type (2015-2020)
11.4 India Viral Vector Manufacturing Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA IMPACT OF COVID-19

12.1 Central & South America Viral Vector Manufacturing Market Size (2015-2020)
12.2 Viral Vector Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vector Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Viral Vector Manufacturing Market Size by Application (2015-2020)

13KEY PLAYERS PROFILES

13.1 BioReliance
  13.1.1 BioReliance Company Details
  13.1.2 BioReliance Business Overview and Its Total Revenue
  13.1.3 BioReliance Viral Vector Manufacturing Introduction
  13.1.4 BioReliance Revenue in Viral Vector Manufacturing Business (2015-2020))
  13.1.5 BioReliance Recent Development and Reaction to COVID-19
13.2 Cobra Biologics
  13.2.1 Cobra Biologics Company Details
  13.2.2 Cobra Biologics Business Overview and Its Total Revenue
  13.2.3 Cobra Biologics Viral Vector Manufacturing Introduction
  13.2.4 Cobra Biologics Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.2.5 Cobra Biologics Recent Development and Reaction to COVID-19
13.3 Oxford BioMedica
  13.3.1 Oxford BioMedica Company Details
  13.3.2 Oxford BioMedica Business Overview and Its Total Revenue
  13.3.3 Oxford BioMedica Viral Vector Manufacturing Introduction
  13.3.4 Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.3.5 Oxford BioMedica Recent Development and Reaction to COVID-19
13.4 UniQure
  13.4.1 UniQure Company Details
  13.4.2 UniQure Business Overview and Its Total Revenue
  13.4.3 UniQure Viral Vector Manufacturing Introduction
  13.4.4 UniQure Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.4.5 UniQure Recent Development and Reaction to COVID-19
13.5 FinVector
  13.5.1 FinVector Company Details
  13.5.2 FinVector Business Overview and Its Total Revenue
  13.5.3 FinVector Viral Vector Manufacturing Introduction
  13.5.4 FinVector Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.5.5 FinVector Recent Development and Reaction to COVID-19
13.6 MolMed
  13.6.1 MolMed Company Details
  13.6.2 MolMed Business Overview and Its Total Revenue
  13.6.3 MolMed Viral Vector Manufacturing Introduction
  13.6.4 MolMed Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.6.5 MolMed Recent Development and Reaction to COVID-19
13.7 MassBiologics
  13.7.1 MassBiologics Company Details
  13.7.2 MassBiologics Business Overview and Its Total Revenue
  13.7.3 MassBiologics Viral Vector Manufacturing Introduction
  13.7.4 MassBiologics Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.7.5 MassBiologics Recent Development and Reaction to COVID-19
13.8 FUJIFILM Diosynth Biotechnologies
  13.8.1 FUJIFILM Diosynth Biotechnologies Company Details
  13.8.2 FUJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
  13.8.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing Introduction
  13.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.8.5 FUJIFILM Diosynth Biotechnologies Recent Development and Reaction to COVID-19
13.9 Lonza
  13.9.1 Lonza Company Details
  13.9.2 Lonza Business Overview and Its Total Revenue
  13.9.3 Lonza Viral Vector Manufacturing Introduction
  13.9.4 Lonza Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.9.5 Lonza Recent Development and Reaction to COVID-19
13.10 Biovian
  13.10.1 Biovian Company Details
  13.10.2 Biovian Business Overview and Its Total Revenue
  13.10.3 Biovian Viral Vector Manufacturing Introduction
  13.10.4 Biovian Revenue in Viral Vector Manufacturing Business (2015-2020)
  13.10.5 Biovian Recent Development and Reaction to COVID-19
13.11 Brammer Bio
  10.11.1 Brammer Bio Company Details
  10.11.2 Brammer Bio Business Overview and Its Total Revenue
  10.11.3 Brammer Bio Viral Vector Manufacturing Introduction
  10.11.4 Brammer Bio Revenue in Viral Vector Manufacturing Business (2015-2020)
  10.11.5 Brammer Bio Recent Development and Reaction to COVID-19

14ANALYST'S VIEWPOINTS/CONCLUSIONS

15APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Viral Vector Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vector Manufacturing Revenue
Table 3. Ranking of Global Top Viral Vector Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vector Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Retroviral Vectors
Table 6. Key Players of Adenoviral Vectors
Table 7. Key Players of Adeno-associated Viral Vectors
Table 8. Key Players of Other Viral Vectors
Table 9. COVID-19 Impact Global Market: (Four Viral Vector Manufacturing Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Viral Vector Manufacturing Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Viral Vector Manufacturing Players to Combat Covid-19 Impact
Table 14. Global Viral Vector Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Viral Vector Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Viral Vector Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Viral Vector Manufacturing Market Share by Regions (2015-2020)
Table 18. Global Viral Vector Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Viral Vector Manufacturing Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Viral Vector Manufacturing Market Growth Strategy
Table 24. Main Points Interviewed from Key Viral Vector Manufacturing Players
Table 25. Global Viral Vector Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 26. Global Viral Vector Manufacturing Market Share by Players (2015-2020)
Table 27. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing as of 2019)
Table 28. Global Viral Vector Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Viral Vector Manufacturing Product Solution and Service
Table 31. Date of Enter into Viral Vector Manufacturing Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 34. Global Viral Vector Manufacturing Market Size Share by Type (2015-2020)
Table 35. Global Viral Vector Manufacturing Revenue Market Share by Type (2021-2026)
Table 36. Global Viral Vector Manufacturing Market Size Share by Application (2015-2020)
Table 37. Global Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 38. Global Viral Vector Manufacturing Market Size Share by Application (2021-2026)
Table 39. North America Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 41. North America Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 42. North America Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 43. North America Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 44. North America Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 45. Europe Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 47. Europe Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 49. Europe Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 51. China Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 52. China Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 53. China Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 54. China Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 55. China Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 56. China Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 57. Japan Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 59. Japan Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 61. Japan Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 65. Southeast Asia Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 67. Southeast Asia Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 69. India Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 70. India Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 71. India Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 72. India Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 73. India Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 74. India Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Viral Vector Manufacturing Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Viral Vector Manufacturing Market Share (2019-2020)
Table 77. Central & South America Viral Vector Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Viral Vector Manufacturing Market Share by Type (2015-2020)
Table 79. Central & South America Viral Vector Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Viral Vector Manufacturing Market Share by Application (2015-2020)
Table 81. BioReliance Company Details
Table 82. BioReliance Business Overview
Table 83. BioReliance Product
Table 84. BioReliance Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 85. BioReliance Recent Development
Table 86. Cobra Biologics Company Details
Table 87. Cobra Biologics Business Overview
Table 88. Cobra Biologics Product
Table 89. Cobra Biologics Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 90. Cobra Biologics Recent Development
Table 91. Oxford BioMedica Company Details
Table 92. Oxford BioMedica Business Overview
Table 93. Oxford BioMedica Product
Table 94. Oxford BioMedica Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 95. Oxford BioMedica Recent Development
Table 96. UniQure Company Details
Table 97. UniQure Business Overview
Table 98. UniQure Product
Table 99. UniQure Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 100. UniQure Recent Development
Table 101. FinVector Company Details
Table 102. FinVector Business Overview
Table 103. FinVector Product
Table 104. FinVector Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 105. FinVector Recent Development
Table 106. MolMed Company Details
Table 107. MolMed Business Overview
Table 108. MolMed Product
Table 109. MolMed Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 110. MolMed Recent Development
Table 111. MassBiologics Company Details
Table 112. MassBiologics Business Overview
Table 113. MassBiologics Product
Table 114. MassBiologics Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 115. MassBiologics Recent Development
Table 116. FUJIFILM Diosynth Biotechnologies Business Overview
Table 117. FUJIFILM Diosynth Biotechnologies Product
Table 118. FUJIFILM Diosynth Biotechnologies Company Details
Table 119. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 120. FUJIFILM Diosynth Biotechnologies Recent Development
Table 121. Lonza Company Details
Table 122. Lonza Business Overview
Table 123. Lonza Product
Table 124. Lonza Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 125. Lonza Recent Development
Table 126. Biovian Company Details
Table 127. Biovian Business Overview
Table 128. Biovian Product
Table 129. Biovian Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 130. Biovian Recent Development
Table 131. Brammer Bio Company Details
Table 132. Brammer Bio Business Overview
Table 133. Brammer Bio Product
Table 134. Brammer Bio Revenue in Viral Vector Manufacturing Business (2015-2020) (Million US$)
Table 135. Brammer Bio Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Viral Vector Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Retroviral Vectors Features
Figure 3. Adenoviral Vectors Features
Figure 4. Adeno-associated Viral Vectors Features
Figure 5. Other Viral Vectors Features
Figure 6. Global Viral Vector Manufacturing Market Share by Application: 2020 VS 2026
Figure 7. Pharmaceutical and Biopharmaceutical Companies Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Viral Vector Manufacturing Report Years Considered
Figure 10. Global Viral Vector Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Viral Vector Manufacturing Market Share by Regions: 2020 VS 2026
Figure 12. Global Viral Vector Manufacturing Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Viral Vector Manufacturing Market Share by Players in 2019
Figure 15. Global Top Viral Vector Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Manufacturing as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing Revenue in 2019
Figure 17. North America Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Viral Vector Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. BioReliance Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. BioReliance Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 26. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Cobra Biologics Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 28. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Oxford BioMedica Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 30. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. UniQure Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 32. FinVector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. FinVector Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 34. MolMed Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MolMed Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 36. MassBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. MassBiologics Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 38. FUJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 40. Lonza Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Lonza Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 42. Biovian Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Biovian Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 44. Brammer Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Brammer Bio Revenue Growth Rate in Viral Vector Manufacturing Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed


More Publications